M Takada

1.4k total citations
59 papers, 1.0k citations indexed

About

M Takada is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, M Takada has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in M Takada's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (22 papers) and Cancer therapeutics and mechanisms (14 papers). M Takada is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (22 papers) and Cancer therapeutics and mechanisms (14 papers). M Takada collaborates with scholars based in Japan, United Kingdom and Australia. M Takada's co-authors include N Masuda, M. Fukuoka, Shunichi Negoro, Kiyoyuki Furuse, Kunihiko Matsui, Y Kusunoki, Mutsuto Kawahara, Mitsumasa Ogawara, Satoshi Kudoh and Nobuhiro Kodama and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Journal of Clinical Microbiology.

In The Last Decade

M Takada

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Takada Japan 16 651 455 363 202 88 59 1.0k
Eleni Karapanagiotou United Kingdom 21 591 0.9× 288 0.6× 460 1.3× 143 0.7× 116 1.3× 68 1.4k
Anne Fajac France 17 257 0.4× 224 0.5× 274 0.8× 138 0.7× 80 0.9× 40 834
Timothy J. O’Rourke United States 15 345 0.5× 210 0.5× 311 0.9× 87 0.4× 197 2.2× 34 962
Tsukasa Aihara Japan 15 230 0.4× 137 0.3× 329 0.9× 156 0.8× 199 2.3× 89 1.0k
Amrish Sharma United States 13 491 0.8× 268 0.6× 381 1.0× 48 0.2× 82 0.9× 24 1.1k
Hsiu-san Lin United States 16 192 0.3× 135 0.3× 162 0.4× 58 0.3× 49 0.6× 29 827
Amy L. Richmond United States 12 443 0.7× 214 0.5× 457 1.3× 161 0.8× 81 0.9× 16 1.2k
Yung‐Chang Lin Taiwan 19 664 1.0× 167 0.4× 273 0.8× 112 0.6× 139 1.6× 49 1.3k
Koji Irie Japan 17 176 0.3× 215 0.5× 215 0.6× 166 0.8× 124 1.4× 54 774
Takeshi Kitazaki Japan 15 582 0.9× 254 0.6× 375 1.0× 108 0.5× 84 1.0× 37 896

Countries citing papers authored by M Takada

Since Specialization
Citations

This map shows the geographic impact of M Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Takada more than expected).

Fields of papers citing papers by M Takada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Takada. The network helps show where M Takada may publish in the future.

Co-authorship network of co-authors of M Takada

This figure shows the co-authorship network connecting the top 25 collaborators of M Takada. A scholar is included among the top collaborators of M Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Takada. M Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Masashi, K Matsui, Nobuyuki Katakami, et al.. (2011). Phase II Study of Gefitinib as a First-line Therapy in Elderly Patients with Pulmonary Adenocarcinoma: West Japan Thoracic Oncology Group Study 0402. Japanese Journal of Clinical Oncology. 41(8). 948–952. 12 indexed citations
2.
Nagao, Hisao, et al.. (2010). Trial use of a polymethylmethacrylate membrane for the removal of free immunoglobulin light chains in dialysis patients. Clinical Kidney Journal. 3(suppl 1). i3–i7. 9 indexed citations
3.
Tsujino, Kayoko, Junji Shiraishi, Taisuke Tsuji, et al.. (2010). Is response rate increment obtained by molecular targeted agents related to survival benefit in the phase III trials of advanced cancer?. Annals of Oncology. 21(8). 1668–1674. 6 indexed citations
4.
Kudoh, Satoshi, Satoaki Nakamura, Takashi Nakano, et al.. (2005). Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group. Lung Cancer. 49(2). 263–269. 11 indexed citations
5.
Endo, Yuichi, et al.. (2001). [A role of visiting nurses in providing the terminal patients with their desirable life-discussion regarding the place of death of the patients who were registered for visiting nurse system].. PubMed. 28 Suppl 1. 128–31. 1 indexed citations
6.
Furuse, Kiyoyuki, Mutsuto Kawahara, Kosei Hasegawa, et al.. (2001). Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer. International Journal of Clinical Oncology. 6(5). 236–241. 30 indexed citations
7.
Konaka, C, Takashi Hirano, H. Kato, et al.. (1999). Comparison of endoscopic features of early-stage squamous cell lung cancer and histological findings. British Journal of Cancer. 80(9). 1435–1439. 24 indexed citations
8.
Takeda, Koji, Shunichi Negoro, S. Kudoh, et al.. (1999). Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer. British Journal of Cancer. 79(9-10). 1462–1467. 35 indexed citations
9.
Fukuoka, M., N Masuda, Shunichi Negoro, et al.. (1997). CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. British Journal of Cancer. 75(2). 306–309. 37 indexed citations
10.
Takada, M, Y Kusunoki, N Masuda, et al.. (1996). Pro-gastrin-releasing peptide(31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase. British Journal of Cancer. 73(10). 1227–1232. 54 indexed citations
11.
Kubo, Akihito, T. Hirashima, Nobuhisa Masuda, et al.. (1996). Point mutations of the topoisomerase IIalpha gene in patients with small cell lung cancer treated with etoposide.. PubMed. 56(6). 1232–6. 32 indexed citations
12.
Takada, M, N Masuda, Eiji Matsuura, et al.. (1995). Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. British Journal of Cancer. 71(1). 160–165. 68 indexed citations
13.
Furuse, Kiyoyuki, Kaoru Kubota, Mutsuto Kawahara, et al.. (1995). Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.. Journal of Clinical Oncology. 13(4). 869–875. 49 indexed citations
14.
Niitsu, Nozomi, et al.. (1994). Therapy-related Acute Non-lymphocytic Leukemia(M2) with 7;11 Chromosome Translocation Induced into Complete Remission by Low Dose Cytosine Arabinoside and Cytarabine Ocfosfate Therapy.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 31(6). 468–471. 2 indexed citations
15.
Takada, M. (1992). IMMUNOHISTOCHEMICAL CLASSIFICATION AND ULTRASTRUCTURAL STUDY OF HYPERPARATHYROIDISM. The Japanese Journal of Urology. 83(11). 1767–1773. 3 indexed citations
16.
Masuda, N, M. Fukuoka, M Takada, et al.. (1992). CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 10(11). 1775–1780. 130 indexed citations
17.
18.
Iguchi, Masanori, Tohru Umekawa, Yasushi Katayama, et al.. (1991). PREPARATION OF A STANDARD DIET FOR OUT-PATIENTS FOR STUDIES OF LITHOGENESIS. The Japanese Journal of Urology. 82(3). 378–387. 1 indexed citations
19.
Narita, Minoru, T. Imada, M Takada, et al.. (1989). Detection of reactivating pseudorabies virus in tissue by immunoperoxidase technique. Journal of Comparative Pathology. 101(2). 151–159. 12 indexed citations
20.
Sakamoto, Tetsuya, et al.. (1988). [A case of Bochdalek hernia accompanied by complicated anomalies of the IVC and hepatic vein].. PubMed. 33(4). 495–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleni Karapanagiotou Breakdown of academic impact, for papers by Anne Fajac Breakdown of academic impact, for papers by Timothy J. O’Rourke Breakdown of academic impact, for papers by Tsukasa Aihara Breakdown of academic impact, for papers by Amrish Sharma Breakdown of academic impact, for papers by Hsiu-san Lin Breakdown of academic impact, for papers by Amy L. Richmond Breakdown of academic impact, for papers by Yung‐Chang Lin Breakdown of academic impact, for papers by Koji Irie Breakdown of academic impact, for papers by Takeshi Kitazaki
Rankless by CCL
2026